Glucagon-like peptide-1 and related agents: Novel anti-arrhythmic agents during myocardial ischemia and reperfusion

International Journal of Cardiology

Volumn 168, Issue 3, 2013, Pages 3119-3120

  Hu, Xiaorong ^a,b   Yang, Xinhong ^a   Jiang, Hong ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b HUBEI POLYTECHNIC UNIVERSITY   (China)

Author keywords

Glucagon like peptide 1; Myocardial ischemia; Reperfusion; Ventricular arrhythmias

Indexed keywords

DIPEPTIDYL PEPTIDASE IV INHIBITOR; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST;

ACUTE HEART INFARCTION; ANTIARRHYTHMIC ACTIVITY; APOPTOSIS; APPARENT LIFE THREATENING EVENT; CARDIAC PATIENT; CARDIOVASCULAR RISK; DRUG DEGRADATION; DRUG STABILITY; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HUMAN; LETTER; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REFRACTORY PERIOD; REPERFUSION INJURY; SUPRAVENTRICULAR PREMATURE BEAT;

GLUCAGON-LIKE PEPTIDE-1; MYOCARDIAL ISCHEMIA; REPERFUSION; VENTRICULAR ARRHYTHMIAS;

ANTI-ARRHYTHMIA AGENTS; GLUCAGON-LIKE PEPTIDE 1; HUMANS; MYOCARDIAL REPERFUSION INJURY;

EID: 84885642547     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.04.064     Document Type: Article

References (12)

1. D.P. Zipes, and H.J.J. Wellens Sudden cardiac death Circulation 98 1998 2334 2351
2. T.J. Kieffer, and J.F. Habener The glucagon-like peptides Endocr Rev 20 1999 876 913
3. L.A. Nikolaidis, D. Elahi, and T. Hentosz Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy Circulation 110 2004 955 961
4. G.G. Sokos, L.A. Nikolaidis, and S. Mankad Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure J Card Fail 12 2006 694 699
5. T. Okerson, and R.J. Chilton The cardiovascular effects of GLP-1 receptor agonists Cardiovasc Ther 30 2012 e146 e155
6. M. Sauve, K. Ban, and M.A. Momen Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice Diabetes 59 2010 1063 1073
7. D.P. Sonne, T. Engstrom, and M. Treiman Protective effects of GLP-1 analogues exendin-4 and GLP-1(9-36) amide against ischemia-reperfusion injury in rat heart Regul Pept 146 2008 243 249
8. L. Timmers, J.P.S. Henriques, and D.P.V. de Kleijn Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury J Am Coll Cardiol 53 2009 501 510
9. B. Hocher, Y. Sharkovska, and M. Mark The novel DPP-4 inhibitors linaglitin and BI 14361 reduce infarct size after myocardial ischemia/reperfusion in rats Int J Cardiol 167 1 2013 Jul 15 87 93
10. K. Chinda, S. Palee, and S. Surinkaew Cardioprotective effect of dipeptidyl peptidase-4 inhibitor during ischemia-reperfusion injury Int J Cardiol 167 2 2013 Jul 31 451 457
11. Z. Kai, W. Yongbo, and Z. Lin Exendin-4 attenuates ischemia-induced ventricular arrhythmias in rats Cardiol J 20 2013 29 33
12. H. Yamamoto, C.E. Lee, and J.N. Marcus Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons J Clin Invest 110 2002 43 52